Sanjeev K
Mumbai
Investment
Investment
time of Investment
About Sanjeev K
(Oncology Formulations/API's/Stem cells/Personalised Immunotherapy/Insilco modelling/Biosimilars) Klab is manufacturing Oncology formulations since 1945. Klab manufactures,markets and outlicenses Oncology/Speciality pharmaceutical formulations,Novel Drug Delivery systems(NDDS),Niche API's.Klab has more than 150 patents granted/under grant using NDDS & Nanotechnology.Klab supplies Oncology products to the needy/NonProfitCo's at cost. Klab is currently actively involved in developing biosimilars ,cell regeneration therapies , personalised cancer immune therapies as also using insilico modelling to develop drugs & cosmeceuticals. Klab was the fi (Show more)
Sanjeev K Invested Companies
Key Focus Areas of invested Startups by Sanjeev K
Biotech Diseases of Ageing Early Cancer-detection +3 more focus areasSanjeev K Recent Experience
Managing Director
Khandelwal Laboratories Private Limited, India
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly reach out to sales@ynos.in
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
